All News
-
Helping with NASA twins study
Stanford scientists and their collaborators found markers of immune-related stress and other molecular changes in the body of NASA astronaut Scott Kelly.
-
Possible ‘bubble boy’ disease therapy
In preclinical trials, Stanford scientists and their collaborators harnessed the gene-editing system CRISPR-Cas9 to replace the mutated gene underpinning the devastating immune disease.
-
New biomedical data science chair named
Sylvia Plevritis, director of the Stanford Center for Cancer Systems Biology, has been tapped to lead the Department of Biomedical Data Science.
-
Med students win Soros Fellowships
An aspiring surgeon and an aspiring stem cell biologist, both currently medical students at Stanford, are among the winners of this year’s Paul & Daisy Soros Fellowships for New Americans.
-
Provost to address med school graduates
Physicist and university provost Persis Drell will be the keynote speaker at this year’s medical school’s graduation ceremony.
-
Viruses protect harmful microbe in CF patients
Some viruses sequester antibiotics in the lungs of CF patients, possibly helping drug-resistant bacterial infections develop in the face of large antibiotic doses, a Stanford-led study has shown.
-
Grant renewal for flu vaccine research
The Stanford Institute for Immunity, Transplantation and Infection will use the grant to try to improve the seasonal flu vaccine by analyzing the human immune system in-depth.
-
Conference on human immune monitoring
The event is set for May 2-3 on campus at the Li Ka Shing Center and will feature leading-edge technology and bioinformatics research by top scientists.
-
Center to enable drug development
A new Stanford center brings together multidisciplinary researchers and advanced technologies to shepherd drug development from preliminary research through preclinical and clinical trials.
-
Drug reduces kidney failure in diabetics
Canagliflozin, a drug approved to lower glucose levels in diabetic patients, can slow the progression of kidney disease, according to a study co-authored by a Stanford Medicine researcher.
-
Identifying familial hypercholesterolemia
Stanford scientists and their collaborators have devised an algorithm to predict the risk of a disease that, untreated, can lead to heart attack or stroke.
-
Ovarian cancer mutations undertested
A large study of women with breast and ovarian cancer has revealed significant gaps between national guidelines for genetic testing and actual testing practices, according to researchers from Stanford and five other institutions.
-
Surgeon Ralph Greco dies at 76
A leader of Stanford’s surgical residency program for close to a decade, Greco died March 31. He was a trailblazer in seeking greater work-life balance for surgical trainees.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.